Additional file 1 of Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial

Harris, Violaine K.; Stark, James; Williams, Armistead; Roche, Morgan; Malin, Michaela; Kumar, Anjali; Carlson, Alyssa L.; Kizilbash, Cara; Wollowitz, Jaina; Andy, Caroline; Gerber, Linda M.; Sadiq, Saud A.

doi:10.6084/m9.figshare.25893797.v1

13287_2024_3765_MOESM1_ESM.docx (21.5 kB)

Additional file 1 of Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial

journal contribution

posted on 2024-05-24, 03:41 authored by Violaine K. Harris, James Stark, Armistead Williams, Morgan Roche, Michaela Malin, Anjali Kumar, Alyssa L. Carlson, Cara Kizilbash, Jaina Wollowitz, Caroline Andy, Linda M. Gerber, Saud A. Sadiq

Supplementary Material 1

Funding

National Multiple Sclerosis Society Biogen

History

Usage metrics

Keywords

Multiple sclerosis Clinical trial Mesenchymal stem cell MSC-NP Intrathecal Cell therapy Progressive multiple sclerosis

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial

Funding

National Multiple Sclerosis Society Biogen

History

Usage metrics

Categories

Keywords

Licence

Exports